Skip to content

Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)

Acupuncture Diagnosis and Treatment of DSM-IV PTSD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00055354
Enrollment
90
Registered
2003-02-27
Start date
2002-09-30
Completion date
2004-05-31
Last updated
2006-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Disorders, Post-Traumatic

Keywords

Acupuncture, Medicine, Chinese Traditional

Brief summary

The purpose of this study is to evaluate acupuncture as a treatment for Post-Traumatic Stress Disorder (PTSD) and to correlate the diagnosis of PTSD with Traditional Chinese Medicine (TCM) diagnostic patterns.

Detailed description

This study will evaluate: 1) the TCM diagnostic differentiation patterns of people who have PTSD as defined by the Diagnostic and Statistical Manual, 4th edition; 2) if an acupuncture treatment approach is acceptable to people with PTSD; and 3) if an acupuncture treatment approach is associated with a reduction in PTSD symptoms that is comparable to that of standard treatments. Because symptoms of depression, insomnia, and pain are often associated with PTSD, we will also evaluate the potential benefit of an acupuncture approach to depression, insomnia, and pain symptoms in people with PTSD. Patients in this study will be randomized to one of three groups. Group A will receive acupuncture therapy. Group B will receive standard Cognitive Behavior Therapy. Group C is a control group and will receive no treatment. Patients in Groups A and B will undergo a total of 24 hours of therapy over the 3 month study course. All patients will have five nontherapeutic study visits; these visits will address diagnosis and assessment. Study visits will include assessments of PTSD symptoms, sleep symptoms, and level of impairment.

Interventions

PROCEDUREAcupuncture
BEHAVIORALCognitive Behavioral Therapy

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* DSM-IV diagnosis of PTSD * Stage I PTSD symptoms * PTSD Symptom Scale-Self Report (PSS-SR) score \> 16 * Meets PSS-SR diagnostic criteria

Exclusion criteria

* Stage I substance abuse and/or dependence in the past 6 months * Psychotic disorder * Inability to commit to treatment or wait-list conditions * Current treatment specifically for PTSD * Certain medical conditions, including thyroid disease, class IV heart failure, active cancer treatment, and uncontrolled diabetes * Pregnant * Use of benzodiazepines, narcotics, opiates, narcotic antagonists, sleep medication, muscle relaxants, analgesics, or sedatives.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026